(19)
(11) EP 4 580 639 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23776761.1

(22) Date of filing: 31.08.2023
(51) International Patent Classification (IPC): 
A61K 31/7052(2006.01)
A61P 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7052; A61P 1/00
(86) International application number:
PCT/US2023/031687
(87) International publication number:
WO 2024/049994 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 01.09.2022 US 202263403130 P

(71) Applicant: Zikani Therapeutics, Inc.
Watertown, MA 02472 (US)

(72) Inventors:
  • BADARINARAYANA, Vasudeo
    Acton, Massachusetts 01720 (US)
  • ICHIKAWA, Yoshitaka
    Laguna Niguel, California 92677 (US)
  • CLARK, Roger B.
    Mesa, Arizona 85207 (US)
  • SHI, Shuhao
    Waltham, Massachusetts 02453 (US)
  • MODUR, Vijay
    Acton, Massachusetts 01720 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) TREATMENT OF FAMILIAL ADENOMATOUS POLYOPSIS USING A 13-MEMBERED MACROLIDE